<scp>DNL</scp>104, a Centrally Penetrant <scp>RIPK</scp>1 Inhibitor, Inhibits <scp>RIP</scp>1 Kinase Phosphorylation in a Randomized Phase I Ascending Dose Study in Healthy Volunteers

Hendrika W. Grievink(Centre for Human Drug Research), Geert Jan Groeneveld(Centre for Human Drug Research)
Clinical Pharmacology & Therapeutics
August 22, 2019
Cited by 77


Related Papers

No related papers found

Powered by citation graph analysis